GlobeNewswire

ADC Therapeutics to Appoint Peter Hug, Ph.D., to Board of Directors

Del

LAUSANNE, Switzerland, Jan. 03, 2019 (GLOBE NEWSWIRE) -- ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of proprietary antibody drug conjugates (ADCs), today announced that Peter Hug, Ph.D., will be appointed to its board of directors. Dr. Hug is a 35-year veteran of Roche. 

Dr. Peter B. Corr, Chairman of the Board of ADC Therapeutics, said, “Peter’s breadth of global commercial and leadership experience from his long tenure at Roche will enhance our efforts as we continue progressing our pipeline of pyrrolobenzodiazepine-based ADCs through the clinic. His commercial expertise will be particularly valuable as we get closer to submitting our first Biologics License Application for ADCT-402 (loncastuximab tesirine), which is currently being evaluated in a pivotal Phase II clinical trial in patients with relapsed or refractory diffuse large B-cell lymphoma. We are thrilled to welcome Peter to our board of directors and look forward to his contributions.”

Dr. Hug held positions of increasing responsibility at Roche from 1983 until his retirement at the end of 2018. He most recently served as Head of Roche Pharma EEMEA Region, which comprises Eastern Europe, Russia, Central Asia, Turkey, Middle East and Africa. Previously, he was Head of Pharma Region Europe, during which time he led a successful transformation of its European commercial operations. Prior to that, Dr. Hug served as Executive Vice President of Roche Pharma Partnering, a role in which he was responsible for licensing, strategic alliances and mergers and acquisitions. In earlier management roles within Roche, he was involved with multiple product launches, including hematology and oncology therapies. Dr. Hug is a graduate of the University of Basel, Switzerland.

Dr. Hug said, “I’m delighted to join ADC Therapeutics’ Board of Directors as the company advances multiple clinical-stage programs with its potent ADCs in both hematological and solid tumor cancers. I look forward to working with the board and leadership team to drive continued progress and ultimately bring important new cancer therapies to patients.”

About ADC Therapeutics

ADC Therapeutics SA is an oncology drug discovery and development company that specializes in the development of proprietary antibody drug conjugates (ADCs) targeting major hematological malignancies and solid tumors. The Company’s ADCs are highly targeted biopharmaceutical drugs that combine monoclonal antibodies specific to surface antigens present on particular tumor cells with a novel class of highly potent pyrrolobenzodiazepine (PBD)-based warheads via a chemical linker. The Company has five PBD-based ADCs in ongoing clinical trials in the USA and Europe, and a deep pipeline of other preclinical ADCs in development. ADC Therapeutics has world-class partners, including AstraZeneca and its global biologics research and development arm, MedImmune. The Company is based in Lausanne (Biopôle), Switzerland and has operations in London, San Francisco and New Jersey. For more information, visit www.adctherapeutics.com.

Investors Contact
Dr. Chris Martin
Chief Executive Officer
Chris.martin@adctherapeutics.com
Tel.: +41 (0) 21 653 0200
  EU Media Contact
Alexandre Müller
Dynamics Group
amu@dynamicsgroup.ch
Tel: +41 (0) 43 268 3231
  USA Media Contact
Tony Plohoros
6 Degrees
tplohoros@6degreespr.com
Tel.: +1 908-591-2839

Om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg saker fra GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra GlobeNewswire

Nasdaq, Inc. Prices €600 Million Senior Notes Offering25.3.2019 20:07:00 CETPressemelding

NEW YORK, March 25, 2019 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (the “Company”) (Nasdaq: NDAQ) today announced that it priced a public offering of €600,000,000 aggregate principal amount of 1.75% senior notes due 2029 (the “Offering”). The Company expects to use the net proceeds from the Offering to refinance indebtedness and for other general corporate purposes. J.P. Morgan Securities plc, Merrill Lynch International, Mizuho International plc and Skandinaviska Enskilda Banken AB (publ) are acting as joint book-running managers for the Offering. HSBC Bank plc, ICBC Standard Bank Plc, Nordea Bank Abp, The Toronto-Dominion Bank and Wells Fargo Securities International Limited are acting as co-managers for the Offering. The Offering is being made pursuant to an effective shelf registration statement, previously filed by the Company with the U.S. Securities and Exchange Commission (the “SEC”). Before investing, you should read the prospectus supplement and accompanying prospectus, as well as oth

‘How to Sell a Massacre’ an Al Jazeera Investigation into Australia’s One Nation Party and Gun Lobby25.3.2019 18:04:00 CETPressemelding

Australia’s One Nation Party Lobbying the National Rifle Association of America (NRA) for Millions of Dollars One Nation’s Chief of Staff, James Ashby, hoped to secure $US20 million political donations to “own the lower house and the upper house” DOHA, Qatar, March 25, 2019 (GLOBE NEWSWIRE) -- A three-year undercover operation by Al Jazeera shows officials from the National Rifle Association of America (NRA) advising delegates from an Australian political party on how to roll back strict gun control laws and how to deal with critics following a mass shooting. Representatives from Pauline Hanson’s One Nation political party were seen seeking millions of dollars in donations from supporters of the U.S. gun lobby in Washington D.C. in order for more guns to flow into Australia. They were coached on how to react if softer gun laws ever led to a mass shooting there. An NRA media liaison officer said the organization remains silent in the immediate aftermath of a multiple shooting, but then

Radient Technologies Inc. Announces Addition of Three Key Members to its Management Team25.3.2019 12:30:00 CETPressemelding

EDMONTON, Alberta, March 25, 2019 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF) is pleased to announce that it has appointed Mr. Adrian Marshall and Mr. James Blakelock to the joint role of Executive Vice President, Corporate Strategy and Planning, and Mr. Bill Wasson to the role of Senior Vice President, Capital Markets and Investor Relations. Working closely with Radient’s existing Management Team and Board of Directors, they will be instrumental in developing, driving and communicating the Company’s corporate strategy and global expansion. Denis Taschuk, CEO & President of Radient, commented: “These additions to our management team are very strategic in nature, and we consider ourselves fortunate to have attracted such top talent as we move forward with our global expansion plans. Both Mr. Marshall and Mr. Blakelock bring to Radient decades of experience working directly with some of the world’s leading rapid growth consu

Forterra Announces Rich Hunter as President of Drainage Pipe & Products and Vik Bhatia of Water Pipe & Products Segments25.3.2019 11:00:00 CETPressemelding

IRVING, Texas, March 25, 2019 (GLOBE NEWSWIRE) -- Forterra, Inc. (“Forterra” or the "Company”) (NASDAQ: FRTA), a leading manufacturer of water and drainage pipe and products in the United States and Eastern Canada, today announced the appointment of Rich Hunter as President of its Drainage Pipe & Products (“Drainage”) segment, and Vik Bhatia as President of its Water Pipe & Products (“Water”) segment. In their new roles, Rich and Vik will continue to report to Jeff Bradley, Chief Executive Officer. Hired as Chief Operating Officer in June 2018, Rich has successfully directed the operations team in delivering measurable improvements in cost, productivity and quality. Vik, who joined Forterra in August of 2017, has had several senior leadership roles, most recently providing focused commercial leadership in the development and execution of sales and customer service strategy for Water. Forterra CEO Jeff Bradley commented, “Rich and Vik have proven themselves as strong leaders who are bot

Nasdaq, Inc. Announces Proposed Senior Notes Offering25.3.2019 10:00:00 CETPressemelding

NEW YORK, March 25, 2019 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (the “Company”) (Nasdaq: NDAQ) today announced that it plans to offer, subject to market and other conditions, Euro-denominated senior notes (the “Offering”). The Company expects to use the net proceeds from the Offering to refinance indebtedness and for other general corporate purposes. J.P. Morgan Securities plc, Merrill Lynch International, Mizuho International plc and Skandinaviska Enskilda Banken AB (publ) will act as joint book-running managers for the Offering. HSBC Bank plc, ICBC Standard Bank Plc, Nordea Bank Abp, The Toronto-Dominion Bank and Wells Fargo Securities International Limited are acting as co-managers for the Offering. The Offering will be made pursuant to an effective shelf registration statement, previously filed by the Company with the U.S. Securities and Exchange Commission (the “SEC”). Before investing, you should read the prospectus supplement and accompanying prospectus, as well as other documents the

cPacket Networks Acquires Solarflare’s SolarCapture Appliance Business25.3.2019 10:00:00 CETPressemelding

Joint Solution Provides cPacket Customers with 40Gbps Visibility into High Speed Critical Networks and Retrospective Analysis of Operational and Security Issues SAN JOSE, Calif., March 25, 2019 (GLOBE NEWSWIRE) -- cPacket Networks, a leading provider of next-generation network performance monitoring and packet broker solutions, has entered into an agreement with Solarflare to acquire the company’s SolarCapture® Appliance business. Solarflare’s SolarCapture Appliance business provides network traffic capture capability for a variety of IT NetOps and SecOps applications including compliance, service-level-agreement monitoring, performance monitoring, security analytics, network forensics, and record keeping. Now an integral part of cPacket’s cStor (integrated packet-forensics for advanced real-time-analytics) product-line, the combined solution provides 100-percent lossless capture for speeds up to 40Gbps. “Making the SolarCapture Appliance technology a permanent addition to our cStor pr